Toggle navigation
OpenPrescribing
Analyse
Area and Practice Dashboards
Practices
PCNs
Sub-ICB Locations
ICBs
Regional Teams
Hospitals
All England
Trends
Trends for BNF sections
Trends for chemicals
Trends for Drug Tariff and Concessions
SICBL improvement radar
More
How to use
Stay in touch
FAQ
API
About
Research
dm+d
Blog
Privacy Policy
Prescribing measures
Show measures categorised as:
All Measures
Standard
Antimicrobial Stewardship
Cardiovascular system
Central Nervous system
Cost Saving
Diabetes
Efficacy
Erectile Dysfunction
Eye
Gastrointestinal system
Generic prescribing
Greener NHS
Infections
Mental Health
Mentioned in Papers
NHS England - items which should not routinely be prescribed in primary care
NICE
National medicines optimisation opportunities
Nutrition
Opioids
Pain
Reproductive system
Respiratory
Safety
See prescribing by all Sub-ICB Locations for:
PREVIEW: Antibiotic stewardship: Access, Watch and Reserve (AWaRe) antibiotics
PREVIEW: Antibiotic stewardship: co-amoxiclav, cephalosporins & quinolones
PREVIEW: Antibiotic stewardship: courses for flucloxacillin 500mg greater than 20 capsules
PREVIEW: Antibiotic stewardship: long term antibiotics for UTIs
PREVIEW: Antibiotic stewardship: long term antibiotics for UTIs compared with methenamine
PREVIEW: Cost of oral nutritional supplementation (ONS) per 1000 patients
PREVIEW: Environmental impact of inhalers - Prescribing of the less environmentally friendly Metered Dose Inhaler (MDI) (excluding salbutamol)
PREVIEW: Fibrates and nicotinic acid
PREVIEW: High-cost drugs for erectile dysfunction
PREVIEW: High dose opioids per 1000 patients
PREVIEW: Higher dose Proton Pump Inhibitors (PPIs)
PREVIEW: High quantity prescribing of morphine sulphate oral solution
PREVIEW: Items which should not routinely be prescribed in primary care - rubefacients, benzydamine, mucopolysaccharide and cooling products
PREVIEW: Low and medium intensity statins
PREVIEW: NHS England Low Priority Treatment - Higher Cost Insulin Pen Needles
PREVIEW: Oral Nutritional Supplementation (ONS) prescribed as ready to serve liquid
PREVIEW: Percentage of available insulins prescribed as biosimilar
PREVIEW: Prescribing of disposable insulin devices
PREVIEW: Prescribing of gabapentin and pregabalin (DDD)
PREVIEW: Prescribing of nimodipine
PREVIEW: Prescribing of non-combination colecalciferol preparations
PREVIEW: Prescribing of oxytetracycline and lymecycline
PREVIEW: Proportion of immediate release oral morphine prescribed as liquid
PREVIEW: Proportion of rivaroxaban and apixaban not prescribed generically
PREVIEW: Seven Day Prescribing for Long Term Conditions
PREVIEW: Short acting beta agonist inhalers
PREVIEW: Specials/imported products
Feedback